“AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets.” – Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to discuss AI in drug discovery. Read the full story here.